In summary, these results demonstrated that upregulation of GSN in CAFs could significantly increase the therapeutic efficacy of PD‐1 blockade and might be a potential therapy strategy to enhance ICI effectiveness in ccRCC. Here, GSN is linked to nonpapillary renal cell carcinoma.